Thornburg Investment Management Inc Pfizer Inc Transaction History

Thornburg Investment Management Inc

$7.17 Billion
Q3 2024

A detailed history of Thornburg Investment Management Inc transactions in Pfizer Inc stock. As of the latest transaction made, Thornburg Investment Management Inc holds 8,842,174 shares of PFE stock, worth $236 Million. This represents 3.57% of its overall portfolio holdings.

Number of Shares

8,842,174

Previous 9,803,509 9.81%

Holding current value

$236 Million

Previous $274 Million 6.71%

% of portfolio

3.57%

Previous 4.04%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$27.7 - $31.39 $26.6 Million - $30.2 Million	-961,335 Reduced 9.81%	8,842,174 $256 Million
Q2 2024 Aug 07, 2024	BUY	$25.26 - $29.6 $23 Million - $27 Million	912,156 Added 10.26%	9,803,509 $274 Million
Q1 2024 May 13, 2024	BUY	$25.89 - $29.73 $25.6 Million - $29.4 Million	988,451 Added 12.51%	8,891,353 $247 Million
Q4 2023 Feb 08, 2024	BUY	$26.13 - $33.94 $1.83 Million - $2.38 Million	70,004 Added 0.89%	7,902,902 $228 Million
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $5.79 Million - $6.77 Million	180,529 Added 2.36%	7,832,898 $260 Million
Q2 2023 Aug 08, 2023	BUY	$36.12 - $41.79 $6.65 Million - $7.7 Million	184,183 Added 2.47%	7,652,369 $281 Million
Q1 2023 May 09, 2023	BUY	$39.39 - $51.28 $1.78 Million - $2.32 Million	45,300 Added 0.61%	7,468,186 $305 Million
Q4 2022 Feb 07, 2023	BUY	$41.75 - $54.5 $2.38 Million - $3.11 Million	57,029 Added 0.77%	7,422,886 $380 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $34.9 Million - $42.6 Million	797,117 Added 12.14%	7,365,857 $322 Million
Q2 2022 Aug 05, 2022	BUY	$46.53 - $55.17 $14.6 Million - $17.3 Million	314,328 Added 5.03%	6,568,740 $344 Million
Q1 2022 May 12, 2022	BUY	$45.75 - $56.69 $13.2 Million - $16.4 Million	288,816 Added 4.84%	6,254,412 $324 Million
Q4 2021 Feb 10, 2022	BUY	$41.32 - $61.25 $944,244 - $1.4 Million	22,852 Added 0.38%	5,965,596 $352 Million
Q3 2021 Nov 10, 2021	BUY	$39.25 - $50.42 $88 Million - $113 Million	2,242,928 Added 60.62%	5,942,744 $256 Million
Q2 2021 Aug 11, 2021	SELL	$35.91 - $40.68 $172,008 - $194,857	-4,790 Reduced 0.13%	3,699,816 $145 Million
Q1 2021 May 14, 2021	BUY	$33.49 - $37.77 $9.83 Million - $11.1 Million	293,432 Added 8.6%	3,704,606 $134 Million
Q4 2020 Feb 09, 2021	SELL	$33.47 - $42.56 $19,446 - $24,727	-581 Reduced 0.02%	3,411,174 $126 Million
Q3 2020 Nov 05, 2020	SELL	$31.75 - $37.25 $983,615 - $1.15 Million	-30,980 Reduced 0.9%	3,411,755 $125 Million
Q2 2020 Aug 07, 2020	SELL	$30.12 - $36.54 $28.1 Million - $34.1 Million	-933,165 Reduced 21.33%	3,442,735 $113 Million
Q1 2020 May 13, 2020	BUY	$27.03 - $38.62 $36.6 Million - $52.3 Million	1,354,898 Added 44.85%	4,375,900 $143 Million
Q4 2019 Feb 10, 2020	BUY	$32.92 - $37.36 $13.1 Million - $14.8 Million	396,628 Added 15.11%	3,021,002 $118 Million
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $66,442 - $86,155	2,045 Added 0.08%	2,624,374 $94.3 Million
Q2 2019 Aug 06, 2019	BUY	$36.98 - $41.52 $12.1 Million - $13.6 Million	327,836 Added 14.29%	2,622,329 $114 Million
Q1 2019 May 07, 2019	SELL	$37.5 - $41.2 $18.7 Million - $20.5 Million	-497,891 Reduced 17.83%	2,294,493 $97.4 Million
Q4 2018 Feb 06, 2019	SELL	$38.47 - $43.86 $6.2 Million - $7.06 Million	-161,048 Reduced 5.45%	2,792,384 $122 Million
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $14.8 Million - $15.7 Million	447,549 Added 17.86%	2,953,432 $107 Million
Q1 2018 May 07, 2018	SELL	$31.91 - $37.02 $9.08 Million - $10.5 Million	-284,469 Reduced 10.19%	2,505,883 $88.9 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $15.4 Million - $17 Million	496,499 Added 21.64%	2,790,352 $99.6 Million
Q2 2017 Aug 14, 2017	BUY	N/A	2,293,853	2,293,853 $77.1 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thornburg Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Thornburg Investment Management Inc with notifications on news.

Account

Thornburg Investment Management Inc Pfizer Inc Transaction History